Development and validation of a molecular prognostic index of bladder cancer based on immunogenomic landscape analysis
Ning Xu(First Affiliated Hospital of Zhengzhou University), Xue‐Yi Xue(Fujian Medical University), Qing‐Shui Zheng(Fujian Medical University), Runan Dong(Fujian Medical University), Yong Wei(Anhui University), Xiaodan Lin(Shanghai Cancer Institute), Yu Chen(New York University), Yu‐Peng Wu(Fujian Medical University), Xiaodong Li(Fujian Medical University), Ye‐Hui Chen(Fujian Medical University), Shao‐Hao Chen(Fujian Medical University), Yun‐Zhi Lin(Fujian Medical University), Zhi‐Bin Ke(Fujian Medical University)
Cited by 34
Related Papers
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
|New England Journal of Medicine|2020|1.1k
Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women
|JAMA Oncology|2018|369
Quantitative Design of Bright Fluorophores and AIEgens by the Accurate Prediction of Twisted Intramolecular Charge Transfer (TICT)
|Angewandte Chemie International Edition|2020|236
Targeted Disruption of <i>Smad4</i> in Cardiomyocytes Results in Cardiac Hypertrophy and Heart Failure
|Circulation Research|2005|140